XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Investments in Nuclear Decommissioning Trusts and Other Special Use Funds (Tables)
6 Months Ended
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Schedule of Fair Value of APS's Nuclear Decommissioning Trust Fund Assets
The following tables present the unrealized gains and losses based on the original cost of the investment and summarizes the fair value of APS’s nuclear decommissioning trusts and other special use fund assets (dollars in thousands):  
June 30, 2024
 Fair ValueTotal
Unrealized
Gains
Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$407,805 $46,789 $454,594 $332,335 $— 
Available for sale-fixed income securities836,344 318,728 1,155,072 (a)9,177 (38,947)
Other1,444 2,287 3,731 (b)399 — 
Total$1,245,593 $367,804 $1,613,397 $341,911 $(38,947)

(a)As of June 30, 2024, the amortized cost basis of these available-for-sale investments is $1,185,000 thousand.
(b)Represents net pending securities sales and purchases.

December 31, 2023
 Fair ValueTotal
Unrealized
Gains
Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$420,680 $40,991 $461,671 $336,555 $— 
Available for sale-fixed income securities781,333 319,594 1,100,927 (a)21,518 (40,868)
Other(767)2,196 1,429 (b)39 — 
Total$1,201,246 $362,781 $1,564,027 $358,112 $(40,868)

(a)As of December 31, 2023, the amortized cost basis of these available-for-sale investments is $1,120,000 thousand.
(b)Represents net pending securities sales and purchases.
Schedule of Realized Gains and Losses and Proceeds from the Sale of Securities by the Nuclear Decommissioning Trust Funds
The following table sets forth APS’s realized gains and losses relating to the sale and maturity of available-for-sale debt securities and equity securities, and the proceeds from the sale and maturity of these investment securities (dollars in thousands):
 Three Months Ended June 30,
 Nuclear Decommissioning TrustsOther Special Use FundsTotal
2024
Realized gains$8,943 $— $8,943 
Realized losses$(3,706)$— $(3,706)
Proceeds from the sale of securities (a)$270,631 $57,874 $328,505 
2023
Realized gains$35,231 $— $35,231 
Realized losses$(11,192)$— $(11,192)
Proceeds from the sale of securities (a)$298,761 $42,141 $340,902 

(a)    Proceeds are reinvested in the nuclear decommissioning trusts and other special use funds, excluding investment fees and amounts reimbursed to the Company for active union employee medical claims from the active union employee medical account.
 Six Months Ended June 30,
 Nuclear Decommissioning TrustsOther Special Use FundsTotal
2024
Realized gains$63,435 $80 $63,515 
Realized losses$(6,521)$— $(6,521)
Proceeds from the sale of securities (a)$648,453 $123,922 $772,375 
2023
Realized gains$36,441 $— $36,441 
Realized losses$(16,886)$— $(16,886)
Proceeds from the sale of securities (a)$434,946 $132,582 $567,528 

(a)    Proceeds are reinvested in the nuclear decommissioning trusts and other special use funds, excluding amounts reimbursed to the Company for active union employee medical claims from the active union employee medical account.
Schedule of Fair Value of Fixed Income Securities, Summarized by Contractual Maturities
The fair value of APS’s fixed income securities, summarized by contractual maturities, at June 30, 2024, is as follows (dollars in thousands):

 Nuclear Decommissioning TrustsCoal Reclamation Escrow AccountActive Union Employee Medical AccountTotal
Less than one year$15,670 $60,841 $37,404 $113,915 
1 year – 5 years258,628 43,419 152,363 454,410 
5 years – 10 years195,624 — 24,701 220,325 
Greater than 10 years366,422 — — 366,422 
Total$836,344 $104,260 $214,468 $1,155,072